Dear Editor, Lymphoma represents 5% of all malignant neoplasm of the head and neck. This region is the second most frequent anatomical site in which the extranodal localizations of lymphoma including the upper respiratory tract can appear, especially the sinonasal tract. The nasal cavity and the paranasal sinuses are affected by a lymphoma on approximately 0.2% to 2% of all types of lymphoma. Into the western population, the lymphoma of the sinonasal tract has B-phenotype and diffuse large B cell lymphoma (DLBCL) histology in 95% of cases.
Standard procedures for lymphoma, before treatment and for therapeutic response evaluation include clinical examination, computed tomography, and/or MRI. Many studies have demonstrated the utility of 18F-FDG PET/CT for staging and for response assessment of lymphoma [1] .
We present here the cases of two patients, with primary lymphoma of the sinonasal tract, in which the 18F-FDG PET/CT scans highlighted pathological uptake, suspecting the presence of residual lymphoma tissue. This hypothesis was refuted by a biopsy of the residual lesions (Fig. 1) .
During a period of 2 years, we identified two patients with primary lymphoma of the sinonasal tract.
The characteristic of the patients are presented in Table 1 . The diagnosis of DLBCL lymphoma was confirmed by histopathological analysis. An initial evaluation included: clinical examination, computed tomography, and 18F-FD G PET/CT scanning. One patient was in firstline of treatment, and one was in relapsed disease. The patients were treated using standard anthracyclin-based chemotherapy associated to monoclonal antibody-Rituximab in one patient, and cytarabine-platine salvage chemotherapy associated to Rituximab in one. Filgrastim 5 μg/kg (G-CSF) was used starting day 8 to day 12. It was proved that it is necessary an interval of 14 days between chemotherapy and PET scan to minimize the risks of false positive results due to the inflammation and increased macrophage activity [2] . An intermediate evaluation was made after two courses of chemotherapy, six days after the end of G-CSF, at day 18. The evaluation includes computed tomography and 18F-FDG PET/CT scans. We compared the results obtained by CT and 18F-FDG PET/CT. For the two patients, CT highlighted residual tissue with focal uptake of FDG on PET/CT. For the first patient, the SUV max decreased from 5.9 to 3.9 (32% response) and for the second patient, SUV max decreased from 4.19 to 3.3 (21% response). These results suspected residual lymphoma disease.
We decided to confirm these results by a new biopsy. The histopathological analysis of the biopsy piece was negative without any residual tumor, ensuring the complete remission. The patients underwent their therapeutic program with consolidation chemotherapy associated to radiotherapy. The sinonasal tract is rarely affected by primary nonHodgkin's lymphoma [3] . The commonest histology is DLBCL with natural history similar to primary nodal NHL [4] . The standard treatment for DLBCL includes anthracyclinbased chemotherapy associated to monoclonal antibodyRituximab [5] . It has been proven that in case of primary lymphoma of the sinonasal tract, the combined modality treatment improves the outcome [4, 6] . It has also been proven that in case of incomplete remission, this type of lymphoma has an elevated risk of relapse, especially on distant sites [7] . It is very important to have a good evaluation tool. 18F-FDG PET/CT has a growing interest for staging [8] and to evaluate the therapeutic response in lymphomas [9, 10] .
In our patients, the initial evaluation by 18F-FDG PET/ CT allows to establish the primary sinuses localisation of the lymphoma. The intermediate PET/CT was positive suspecting a residual tissue. The biopsy of the sinuses and a histopathological analysis were in favor of complete remission showing only an important inflammatory reaction. The presence of this inflammatory tissue gave a false positive image on PET/CT.
The patients are alive, in complete remission at distance from the end of treatment (12 and 24 months.
For the patients with non-Hodgkin's lymphoma affecting the sinonasal tract, treated by chemotherapy, is usual to find an important inflammatory tissue at the clinical and histological examination. We believe that in case of residual lesions on 18F-FDG PET/CT or on computed tomography, these examinations must be completed by a biopsy of the lesions to confirm or refute the complete remission.
